vimarsana.com

Latest Breaking News On - Retina specialists - Page 8 : vimarsana.com

Clearside Biomedical Announces Fourth Quarter And Full Year 2023 Financial Results And Provides Corporate Update

Clearside Biomedical Announces Fourth Quarter And Full Year 2023 Financial Results And Provides Corporate Update
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Hawaii
United-states
American
Hawaiian
Remy-bernarda
George-lasezkay
Jenny-kobin
Clearside-biomedical-inc
Biocryst-pharmaceuticals
Macula-society
Exchange-commission
American-society-of-retina-specialists

Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United-states
Hawaii
Hawaiian
American
Remy-bernarda
Jenny-kobin
George-lasezkay
Linkedin
American-society-of-retina-specialists
Macula-society
Nasdaq
Clearside-biomedical-inc

Don't Get Burned: Retina Specialists Share Eclipse Safety Tips

On April 8, 2024, 40 million people across the United States, Canada, and Mexico will have the opportunity to experience a true celestial spectacle, a rare tota

Canada
Mexico
Chicago
Illinois
United-states
American
Geoffreyg-emerson
American-society-of-retina-specialists
International-organization-for-standardization
American-society
Retina-specialists

Apellis Appoints Leading Expert Dr. Philip Ferrone as Chief Medical Retina Advisor

WALTHAM, Mass., March 11, 2024 (GLOBE NEWSWIRE) Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that leading retina specialist P.

Union-college
New-york
United-states
American
Meredith-kaya
Philip-ferrone
Lissa-pavluk
Caroline-baumal
Twitter
American-society-of-retina-specialists
Linkedin
Apellis-pharmaceuticals-inc

Oculis Provides Updates at R&D Day on Late-Stage Clinical Trials and Announces Key Leadership Appointments

Completed enrollment in Phase 2b RELIEF trial of Licaminlimab , anti-TNF alpha eye drops in Dry Eye Disease ; topline results expected in Q2 2024Second Phase 3 trial of OCS-01 eye drops in Diabetic.

Virginia
United-states
Massachusetts
Eastern-virginia-medical-school
Paris
France-general
France
Vermont
Boston
Switzerland
American
Sylvia-cheung

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.